Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2024 Filed Mar 18, 2024 19:26 UTC |
ROUSSEAU JON BDirector · See Remarks
|
PurchaseCommon Stock | 18,400 | $8.09 | $148,856.00 |
DisclosureSEC source: 0000908834-24-000102 · form4.xml · nonDerivative · entry 2 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Rousseau Family Trust Disclosed balance after: 369,763 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 19:26 UTC |
ROUSSEAU JON BDirector · See Remarks
|
PurchaseCommon Stock | 18,400 | $8.09 | $148,856.00 |
DisclosureSEC source: 0000908834-24-000102 · form4.xml · nonDerivative · entry 1 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,025,636 F1 · balance_after: Includes 967,884 shares of the Issuer's common stock underlying restricted stock units ("RSUs") which will vest in twelve equal quarterly installments commencing on April 25, 2024. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:34 UTC |
Phipps Jennifer AChief Accounting Officer
|
PurchaseCommon Stock | 12,300 | $8.14 | $100,122.00 |
DisclosureSEC source: 0000908834-24-000096 · form4.xml · nonDerivative · entry 1 Phipps Jennifer A · CIK 0001891391 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,618 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.13 to $8.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:34 UTC |
Mattingly James F JrSee Remarks
|
PurchaseCommon Stock | 12,280 | $8.18 | $100,450.40 |
DisclosureSEC source: 0000908834-24-000095 · form4.xml · nonDerivative · entry 1 Mattingly James F Jr · CIK 0001891168 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,700 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.15 to $8.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:33 UTC |
ROUSSEAU JON BDirector · See Remarks
|
PurchaseCommon Stock | 37,405 | $8.12 | $303,728.60 |
DisclosureSEC source: 0000908834-24-000094 · form4.xml · nonDerivative · entry 1 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,352 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.95 to $8.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 19:25 UTC Amendment |
ROUSSEAU JON BDirector · See Remarks
|
PurchaseCommon Stock | 37,405 | $8.12 | $303,728.60 |
DisclosureSEC source: 0000908834-24-000101 · form4.xml · nonDerivative · entry 1 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,007,236 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.95 to $8.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: This amendment is being filed solely to restate the amount of securities beneficially owned following the transaction reported in the original Form 4 filed on March 15, 2024, which inadvertently excluded the shares of common stock underlying restricted stock units, as further described in footnote 3 herein. F3 · balance_after: Includes 967,884 shares of the Issuer's common stock underlying restricted stock units ("RSUs") which will vest in twelve equal quarterly installments commencing on April 25, 2024. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:15 UTC |
McMaude Michael ASee Remarks
|
GrantCommon Stock | 51,442 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008838 · ownership.xml · nonDerivative · entry 1 McMaude Michael A · CIK 0001891172 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,090 F1 · kind: On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:15 UTC |
Barnes Robert AllenPresident, Community Living
|
GrantCommon Stock | 46,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008837 · ownership.xml · nonDerivative · entry 1 Barnes Robert Allen · CIK 0001891193 · President, Community Living 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,744 F1 · kind: On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:15 UTC |
Mattingly James F JrSee Remarks
|
GrantCommon Stock | 77,164 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008836 · ownership.xml · nonDerivative · entry 1 Mattingly James F Jr · CIK 0001891168 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,420 F1 · kind: On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:15 UTC |
Phipps Jennifer AChief Accounting Officer
|
GrantCommon Stock | 144,682 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008833 · ownership.xml · nonDerivative · entry 1 Phipps Jennifer A · CIK 0001891391 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,318 F1 · kind: On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:15 UTC |
Yowler JenniferPresident, PharMerica
|
GrantCommon Stock | 57,880 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008831 · ownership.xml · nonDerivative · entry 1 Yowler Jennifer · CIK 0001995316 · President, PharMerica 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,880 F1 · kind: On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:15 UTC |
Nalley Lisa ASee Remarks
|
GrantCommon Stock | 96,454 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008832 · ownership.xml · nonDerivative · entry 1 Nalley Lisa A · CIK 0001891179 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,594 F1 · kind: On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:15 UTC |
REED STEVEN SSee Remarks
|
GrantCommon Stock | 54,658 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008830 · ownership.xml · nonDerivative · entry 1 REED STEVEN S · CIK 0001215275 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,914 F1 · kind: On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:15 UTC |
ROUSSEAU JON BDirector · See Remarks
|
GrantCommon Stock | 967,884 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008829 · ownership.xml · nonDerivative · entry 1 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 969,831 F1 · kind: On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in twelve equal quarterly installments commencing on April 25, 2024. Each RSU represents a contingent right to receive one share of common stock upon settlement. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
McMaude Michael ASee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 18,670 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008838 · ownership.xml · derivative · entry 3 McMaude Michael A · CIK 0001891172 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,670 Underlying: Common Stock · 18,670 shares Expires 2034-01-25 F3 · kind: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. F3 · derivative.exercise_date: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
McMaude Michael ASee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 33,349 | $0.00 Strike: $15.92 | $0.00 |
DisclosureSEC source: 0000950170-24-008838 · ownership.xml · derivative · entry 2 McMaude Michael A · CIK 0001891172 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,048 Underlying: Common Stock · 33,349 shares Expires 2031-05-12 F2 · derivative.exercise_date: Options acquired represent options originally granted on May 12, 2021, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2022. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Barnes Robert AllenPresident, Community Living
|
GrantStock Options (Right to Buy) · Derivative | 16,919 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008837 · ownership.xml · derivative · entry 4 Barnes Robert Allen · CIK 0001891193 · President, Community Living 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,919 Underlying: Common Stock · 16,919 shares Expires 2034-01-25 F4 · kind: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. F4 · derivative.exercise_date: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Barnes Robert AllenPresident, Community Living
|
GrantStock Options (Right to Buy) · Derivative | 2,944 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000950170-24-008837 · ownership.xml · derivative · entry 3 Barnes Robert Allen · CIK 0001891193 · President, Community Living 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,832 Underlying: Common Stock · 2,944 shares Expires 2030-05-12 F3 · kind: Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. F3 · derivative.exercise_date: Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Barnes Robert AllenPresident, Community Living
|
GrantStock Options (Right to Buy) · Derivative | 35,331 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0000950170-24-008837 · ownership.xml · derivative · entry 2 Barnes Robert Allen · CIK 0001891193 · President, Community Living 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,993 Underlying: Common Stock · 35,331 shares Expires 2029-09-24 F2 · kind: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock (the "Stock Split"), which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. F2 · derivative.exercise_date: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock (the "Stock Split"), which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Mattingly James F JrSee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 28,005 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008836 · ownership.xml · derivative · entry 3 Mattingly James F Jr · CIK 0001891168 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,005 Underlying: Common Stock · 28,005 shares Expires 2034-01-25 F3 · kind: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. F3 · derivative.exercise_date: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Mattingly James F JrSee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 184,506 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0000950170-24-008836 · ownership.xml · derivative · entry 2 Mattingly James F Jr · CIK 0001891168 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 553,520 Underlying: Common Stock · 184,506 shares Expires 2029-09-24 F2 · kind: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. F2 · derivative.exercise_date: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Phipps Jennifer AChief Accounting Officer
|
GrantStock Options (Right to Buy) · Derivative | 52,509 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008833 · ownership.xml · derivative · entry 4 Phipps Jennifer A · CIK 0001891391 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,509 Underlying: Common Stock · 52,509 shares Expires 2034-01-25 F4 · kind: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. F4 · derivative.exercise_date: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Phipps Jennifer AChief Accounting Officer
|
GrantStock Options (Right to Buy) · Derivative | 5,888 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000950170-24-008833 · ownership.xml · derivative · entry 3 Phipps Jennifer A · CIK 0001891391 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,655 Underlying: Common Stock · 5,888 shares Expires 2030-05-12 F3 · derivative.exercise_date: Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Phipps Jennifer AChief Accounting Officer
|
GrantStock Options (Right to Buy) · Derivative | 35,331 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0000950170-24-008833 · ownership.xml · derivative · entry 2 Phipps Jennifer A · CIK 0001891391 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,993 Underlying: Common Stock · 35,331 shares Expires 2029-09-24 F2 · derivative.exercise_date: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024 (the "Stock Split"). Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Yowler JenniferPresident, PharMerica
|
GrantStock Options (Right to Buy) · Derivative | 21,004 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008831 · ownership.xml · derivative · entry 4 Yowler Jennifer · CIK 0001995316 · President, PharMerica 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,004 Underlying: Common Stock · 21,004 shares Expires 2034-01-25 F4 · kind: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. F4 · derivative.exercise_date: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Yowler JenniferPresident, PharMerica
|
GrantStock Options (Right to Buy) · Derivative | 17,665 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000950170-24-008831 · ownership.xml · derivative · entry 3 Yowler Jennifer · CIK 0001995316 · President, PharMerica 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,996 Underlying: Common Stock · 17,665 shares Expires 2030-05-12 F3 · kind: Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. F3 · derivative.exercise_date: Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Yowler JenniferPresident, PharMerica
|
GrantStock Options (Right to Buy) · Derivative | 17,665 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0000950170-24-008831 · ownership.xml · derivative · entry 2 Yowler Jennifer · CIK 0001995316 · President, PharMerica 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,996 Underlying: Common Stock · 17,665 shares Expires 2029-09-24 F2 · kind: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock (the "Stock Split"), which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. F2 · derivative.exercise_date: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock (the "Stock Split"), which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Nalley Lisa ASee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 35,006 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008832 · ownership.xml · derivative · entry 4 Nalley Lisa A · CIK 0001891179 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,006 Underlying: Common Stock · 35,006 shares Expires 2034-01-25 F4 · kind: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. F4 · derivative.exercise_date: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Nalley Lisa ASee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 3,925 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000950170-24-008832 · ownership.xml · derivative · entry 3 Nalley Lisa A · CIK 0001891179 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,777 Underlying: Common Stock · 3,925 shares Expires 2030-05-12 F3 · derivative.exercise_date: Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
Nalley Lisa ASee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 35,331 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0000950170-24-008832 · ownership.xml · derivative · entry 2 Nalley Lisa A · CIK 0001891179 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,993 Underlying: Common Stock · 35,331 shares Expires 2029-09-24 F2 · derivative.exercise_date: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024 (the "Stock Split"). Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
REED STEVEN SSee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 19,837 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008830 · ownership.xml · derivative · entry 3 REED STEVEN S · CIK 0001215275 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,837 Underlying: Common Stock · 19,837 shares Expires 2034-01-25 F3 · kind: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. F3 · derivative.exercise_date: Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
REED STEVEN SSee Remarks
|
GrantStock Options (Right to Buy) · Derivative | 60,847 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0000950170-24-008830 · ownership.xml · derivative · entry 2 REED STEVEN S · CIK 0001215275 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,543 Underlying: Common Stock · 60,847 shares Expires 2029-09-24 F2 · kind: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. F2 · derivative.exercise_date: Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
ROUSSEAU JON BDirector · See Remarks
|
GrantStock Options (Right to Buy) · Derivative | 320,086 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008829 · ownership.xml · derivative · entry 7 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,086 Underlying: Common Stock · 320,086 shares Expires 2034-01-25 F8 · kind: Options granted on January 25, 2024 which vest in twelve equal quarterly installments commencing on April 25, 2024. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. F8 · derivative.exercise_date: Options granted on January 25, 2024 which vest in twelve equal quarterly installments commencing on April 25, 2024. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Read SEC document |
| January 25, 2024 Filed Jan 30, 2024 21:15 UTC |
ROUSSEAU JON BDirector · See Remarks
|
GrantStock Options (Right to Buy) · Derivative | 955,823 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0000950170-24-008829 · ownership.xml · derivative · entry 6 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,327,081 Underlying: Common Stock · 955,823 shares Expires 2029-10-16 F7 · derivative.exercise_date: Options acquired represent options originally granted on October 16, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining 46,803 unvested options are subject to a time-based vesting schedule, which options shall fully vest on March 5, 2024. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. Read SEC document |
| November 22, 2023 Filed Jan 30, 2024 21:15 UTC |
ROUSSEAU JON BDirector · See Remarks
|
GrantStock Options (Right to Buy) · Derivative | 628,108 | $0.00 Strike: $22.29 | $0.00 |
DisclosureSEC source: 0000950170-24-008829 · ownership.xml · derivative · entry 5 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628,108 Underlying: Common Stock · 628,108 shares Expires 2033-11-22 F6 · derivative.exercise_date: Options acquired represent options originally granted on November 22, 2023 which vest one-third on May 22, 2024, and the remaining two-thirds to vest in equal monthly installments over the two years subsequent to the grant date. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Reflects the Stock Split. Read SEC document |
| November 21, 2023 Filed Jan 30, 2024 21:15 UTC |
ROUSSEAU JON BDirector · See Remarks
|
Disposition to issuerStock Options (Right to Buy) · Derivative | 412,195 | $15.92 Strike: $6.37 | $6,562,144.40 |
DisclosureSEC source: 0000950170-24-008829 · ownership.xml · derivative · entry 4 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By The Margaret Rousseau Children Trust Disclosed balance after: 534,676 Underlying: Common Stock · 412,195 shares Expires 2029-10-16 F4 · kind: A portion of the option was canceled by mutual agreement of the Trust and Issuer. The Trust received $6,562,500 as consideration for the cancellation. Such cancelled securities were not originally included on the Form 3 filed by the reporting person on January 26, 2024. Reflects the Stock Split. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 21, 2023 Filed Jan 30, 2024 21:15 UTC |
ROUSSEAU JON BDirector · See Remarks
|
Disposition to issuerStock Options (Right to Buy) · Derivative | 215,912 | $15.92 Strike: $6.37 | $3,437,319.04 |
DisclosureSEC source: 0000950170-24-008829 · ownership.xml · derivative · entry 3 ROUSSEAU JON B · CIK 0001579775 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,258 Underlying: Common Stock · 215,912 shares Expires 2029-10-16 F2 · kind: A portion of the option was canceled by mutual agreement of the reporting person and Issuer. The reporting person received $3,437,500 as consideration for the cancellation. Such cancelled securities were not included on the Form 3 filed by the reporting person on January 26, 2024. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024 (the "Stock Split"). Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. F3 · derivative.exercise_date: Options granted on October 16, 2019, of which, the remaining 46,803 unvested options will vest fully on March 5, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.